Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a treatment-refractory malignancy with poor prognosis. It is urgent to identify novel and valid biomarkers to predict the progress and prognosis of PDAC. The S100A family have been identified as being involved in cell proliferation, migrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong-Bin, Wang, Jian-Li, Jin, Xiao-Dong, Zhao, Lei, Ye, Hui-Li, Kuang, Yan-bei, Ma, Yong, Jiang, Xiang-Yan, Yu, Ze-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447682/
https://www.ncbi.nlm.nih.gov/pubmed/34530774
http://dx.doi.org/10.1186/s12885-021-08769-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447682/
https://www.ncbi.nlm.nih.gov/pubmed/34530774
http://dx.doi.org/10.1186/s12885-021-08769-6

Ejemplares similares